Centenial Surgical Suture Ltd (531380)

Centenial Surgical Suture Ltd announced that Executive Director Anuradha Kashikar has resigned from her role effective October 5, 2026. The departure is attributed to personal reasons, with confirmation that there are no other material reasons. The micro-cap surgical equipment maker (market cap Rs 35 Cr, TTM revenue Rs 56 Cr) delivered a net profit of Rs 0.74 Cr in Q1 FY27 (ended June 2026) following a loss of Rs 2.21 Cr in FY26. Management has not yet announced a successor for the executive board role.

• Executive Director Anuradha Kashikar (DIN: 00804831) resigned effective October 5, 2026
• Resignation cited personal reasons with no other material reasons stated
• Company reported Rs 15.34 Cr in revenue for the recent June 2026 quarter against Rs 35 Cr market cap

Centenial Surgical Suture Ltd has scheduled its 31st Annual General Meeting (AGM) for Monday, September 28, 2026, at 2:00 PM IST via Video Conferencing / Other Audio-Visual Means. The company has fixed Monday, September 21, 2026, as the cut-off date to determine shareholder eligibility for voting. Remote e-voting will commence on September 24, 2026, at 9:00 AM IST and conclude on September 27, 2026, at 5:00 PM IST. This is a standard corporate compliance announcement with no material financial impact.

• 31st AGM scheduled for Monday, September 28, 2026 at 02:00 p.m. IST via Video Conferencing.
• Cut-off date for e-voting eligibility fixed as Monday, September 21, 2026.
• Remote e-voting opens on Thursday, September 24, 2026 at 9:00 a.m. IST.
• Remote e-voting closes on Sunday, September 27, 2026 at 5:00 p.m. IST.

Centenial Surgical Suture Ltd has announced the closure of its Share Transfer Books and Register of Members from September 22, 2026 to September 28, 2026 (both days inclusive). The book closure is scheduled in preparation for its 31st Annual General Meeting (e-AGM) to be held on September 28, 2026. The micro-cap company (market cap ₹31 Cr) generated ₹53.84 Cr revenue and a net loss of ₹2.2 Cr in FY26. This filing is purely a routine statutory compliance under SEBI LODR Regulation 42.

• 31st Annual General Meeting (e-AGM) scheduled for September 28, 2026
• Book closure from September 22, 2026 to September 28, 2026 (both days inclusive)
• Board approval for the book closure granted on August 14, 2026

Centenial Surgical Suture Ltd announced the appointment of M/s. Utsav Shah & Associates, Chartered Accountants (FRN 140896W), as the Internal Auditor of the company for FY 2026-2027. The decision was approved by the Audit Committee and Board of Directors during their meeting on August 14, 2026. The lead auditor brings approximately a decade of experience in auditing and assurance services. This constitutes standard statutory and regulatory compliance under the Companies Act, 2013, with no material financial impact.

• Appointed M/s. Utsav Shah & Associates (FRN: 140896W) as Internal Auditor for FY 2026-2027
• Board meeting approving the appointment concluded on August 14, 2026 (05:00 PM to 05:30 PM)
• Lead auditor Shri Utsav Shah brings approximately 10 years of experience in auditing and assurance

Centenial Surgical Suture Ltd has announced key managerial changes effective August 14, 2026. Anuradha Kashikar, spouse of Managing Director Vijay Majrekar, has resigned from the position of Chief Financial Officer citing personal reasons. The Board has appointed Ms. Sapna Mhatre, who has been with the company since September 2001 as Chief Administrative Officer, as the new CFO. The micro-cap company currently operates with a market cap of ₹31 Cr and TTM revenue of ₹56 Cr.

• Anuradha Kashikar resigned as CFO and KMP effective August 14, 2026, citing personal reasons.
• Sapna Mhatre appointed as Chief Financial Officer and KMP effective August 14, 2026.
• Incoming CFO Sapna Mhatre has been in employment with the company since September 2001.
• Outgoing CFO is the spouse of MD Vijay Majrekar; incoming CFO is confirmed unrelated to any director.

Centenial Surgical Suture Ltd has appointed M/s. Utsav Shah & Associates, Chartered Accountants (FRN 140896W), as its Internal Auditor for Financial Year 2026-2027. The appointment was approved by the Audit Committee and Board of Directors at their meeting held on August 14, 2026. The meeting commenced at 05:00 p.m. and concluded at 05:30 p.m. This is a standard statutory compliance appointment under the Companies Act, 2013, and SEBI LODR Regulations.

• Appointment of M/s. Utsav Shah & Associates (FRN 140896W) as Internal Auditor
• Appointed for a term covering the Financial Year 2026-2027
• Auditor brings approximately a decade worth of experience in auditing and assurance
• Board meeting approving the appointment held on August 14, 2026, from 05:00 p.m. to 05:30 p.m.

Centenial Surgical Suture Ltd announced that its Board of Directors met on August 14, 2026, and approved the standalone unaudited financial results for the quarter ended June 30, 2026. The Board appointed Ms. Sapna Mhatre as the new Chief Financial Officer (KMP) effective August 14, 2026, following the resignation of Ms. Anuradha Kashikar from the CFO post. Ms. Kashikar continues as Executive Director with a proposed 3-year term extension from April 1, 2027, to March 31, 2030, subject to shareholder approval. The company's 31st Annual General Meeting is scheduled for September 28, 2026.

• Appointed Ms. Sapna Mhatre as Chief Financial Officer (KMP) effective August 14, 2026.
• Accepted resignation of Ms. Anuradha Kashikar as CFO; approved her re-appointment as Executive Director for 3 years (April 1, 2027 to March 31, 2030).
• Approved Standalone Un-Audited Financial Results along with Limited Review Report for Q1 ended June 30, 2026.
• Appointed M/s. Utsav Shah & Associates, Chartered Accountants, as Internal Auditor for FY 2026-2027.
• Scheduled the 31st Annual General Meeting for Monday, September 28, 2026.

Centenial Surgical Suture has scheduled a board meeting on August 14, 2026, to approve standalone financial results for the quarter ended June 30, 2026. The board will also consider the re-appointment of Ms. Anuradha Kashikar as Executive Director for a three-year term and appoint M/s. Utsav Shah & Associates as Internal Auditors for FY27. This follows a weak FY26 where the company reported a net loss of ‡2.2 crore on ‡53.84 crore revenue. Investors will be looking for signs of recovery after the significant ‡2.31 crore loss reported in the March 2026 quarter.

• Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results.
• Proposed re-appointment of Ms. Anuradha Kashikar as Executive Director for a period of 3 years.
• Appointment of M/s. Utsav Shah & Associates as Internal Auditors for the 2026-2027 financial year.
• Trading window for company securities remains closed from July 1, 2026, until August 16, 2026.
• Company to fix dates for the 31st Annual General Meeting (AGM) during this meeting.